The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Open accessAbstract
Large amounts of new data on the natural history and treatment of chronic hepatitis B virus (HBV) infection have become available since 2005. These include long-term follow-up studies in large community-based cohorts or asymptomatic subjects with chronic HBV infection, further studies on the role of HBV genotype/naturally occurring HBV mutations, treatment of drug resistance and new therapies. In addition, Pegylated interferon alpha2a, entecavir and telbivudine have been approved globally. To update HBV management guidelines, relevant new data were reviewed and assessed by experts from the region, and the significance of the reported findings were discussed and debated. The earlier "Asian-Pacific consensus statement on the management of chronic hepatitis B" was revised accordingly. The key terms used in the statement were also defined. The new guidelines include general management, special indications for liver biopsy in patients with persistently normal alanine aminotransferase, time to start or stop drug therapy, choice of drug to initiate therapy, when and how to monitor the patients during and after stopping drug therapy. Recommendations on the therapy of patients in special circumstances, including women in childbearing age, patients with antiviral drug resistance, concurrent viral infection, hepatic decompensation, patients receiving immune-suppressive medications or chemotherapy and patients in the setting of liver transplantation, are also included.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Self-citationPanahi, M., Naderi, M., Morteza, T. S., & Parizadeh, S. M. J. (2007) · Cited by 1,722
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
Iloeje, U. H., Yang, H., Su, J., Jen, C., You, S., & Chen, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.016 · Cited by 1,528
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Lau, G. K. K., Piratvisuth, T., Luo, K. X., Marcellin, P., Thongsawat, S., Cooksley, G., Gane, E., Fried, M. W., Chow, W. C., Paik, S. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043470 · Cited by 1,519
Self-citationA Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
Chang, T.-T., Gish, R. G., de Man, R., Gadano, A., Sollano, J., Chao, Y.-C., Lok, A. S., Han, K.-H., Goodman, Z., Zhu, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051285 · Cited by 1,444
Self-citationSummers, J., & Mason, W. S. (1982) · Cell · doi:10.1016/0092-8674(82)90157-x · Cited by 1,443
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
Self-citationEntecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
Lai, C.-L., Shouval, D., Lok, A. S., Chang, T.-T., Cheinquer, H., Goodman, Z., DeHertogh, D., Wilber, R., Zink, R. C., Cross, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051287 · Cited by 1,188
Janssen, H. L., van Zonneveld, M., Senturk, H., Zeuzem, S., Akarca, U. S., Cakaloglu, Y., Simon, C., So, T. M., Gerken, G., de Man, R. A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17701-0 · Cited by 1,162
Marcellin, P., Lau, G. K. K., Bonino, F., Farci, P., Hadziyannis, S., Jin, R., Lu, Z.-M., Piratvisuth, T., Germanidis, G., Yurdaydin, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040431 · Cited by 1,145
Self-citationLong-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
Hadziyannis, S. J., Tassopoulos, N. C., Heathcote, E. J., Chang, T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S. G., Goodman, Z., Ma, J., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.020 · Cited by 881
Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B
Niederau, C., Heintges, T., Lange, S., Goldmann, G., Niederau, C. M., Mohr, L., & Häussinger, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342202 · Cited by 803
Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B
Lai, C.-L., Gane, E., Liaw, Y.-F., Hsu, C.-W., Thongsawat, S., Wang, Y., Chen, Y., Heathcote, E. J., Rasenack, J., Bzowej, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066422 · Cited by 773
Self-citationLong-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
Hsu, Y.-S., Chien, R.-N., Yeh, C.-T., Sheen, I.-S., Chiou, H.-Y., Chu, C.-M., & Liaw, Y.-F. (2002) · Hepatology · doi:10.1053/jhep.2002.33638 · Cited by 705
Self-citationManagement of hepatitis B: Summary of a clinical research workshop†
Hoofnagle, J. H., Doo, E., Liang, T. J., Fleischer, R., & Lok, A. S. F. (2007) · Hepatology · doi:10.1002/hep.21627 · Cited by 628
Leung, N. W. Y., Lai, C.-L., Chang, T.-T., Guan, R., Lee, C.-M., Ng, K.-Y., Lim, S.-G., Wu, P.-C., Dent, J. C., Edmundson, S., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.25084 · Cited by 626
Self-citationThe development of cirrhosis in patients with chronic type B hepatitis: A prospective study
Liaw, Y.-F., Tai, D.-I., Chu, C.-M., & Chen, T.-J. (1988) · Hepatology · doi:10.1002/hep.1840080310 · Cited by 612
Self-citationHepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
Yu, M.-W., Yeh, S.-H., Chen, P.-J., Liaw, Y.-F., Lin, C.-L., Liu, C.-J., Shih, W.-L., Kao, J.-H., Chen, D.-S., & Chen, C.-J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji043 · Cited by 569
Self-citationKao, J., Chen, P., Lai, M., & Chen, D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50053 · Cited by 536
Self-citationCooksley, W. G. E., Piratvisuth, T., Lee, S. ‐., Mahachai, V., Chao, Y. ‐., Tanwandee, T., Chutaputti, A., Chang, W. Y., Zahm, F. E., & Pluck, N. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00450.x · Cited by 475
Self-citationHui, C., Cheung, W. W. W., Zhang, H., Au, W., Yueng, Y., Leung, A. Y. H., Leung, N., Luk, J. M., Lie, A. K. W., Kwong, Y., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.015 · Cited by 453
Self-citationLok, A. S., Zoulim, F., Locarnini, S., Bartholomeusz, A., Ghany, M. G., Pawlotsky, J.-M., Liaw, Y.-F., Mizokami, M., & Kuiken, C. (2007) · Hepatology · doi:10.1002/hep.21698 · Cited by 447
Self-citationEntecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B
Sherman, M., Yurdaydin, C., Sollano, J., Silva, M., Liaw, Y., Cianciara, J., Boron–Kaczmarska, A., Martin, P., Goodman, Z., Colonno, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.007 · Cited by 413
Self-citationvan Bömmel, F., Wünsche, T., Mauss, S., Reinke, P., Bergk, A., Schürmann, D., Wiedenmann, B., & Berg, T. (2004) · Hepatology · doi:10.1002/hep.20464 · Cited by 389
Keeffe, E. B., Dieterich, D. T., Han, S. B., Jacobson, I. M., Martin, P., Schiff, E. R., Tobias, H., & Wright, T. L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.016 · Cited by 374
Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B
Gish, R. G., Lok, A. S., Chang, T., de Man, R. A., Gadano, A., Sollano, J., Han, K., Chao, Y., Lee, S., Harris, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.025 · Cited by 367
Self-citationChu, C., & Liaw, Y. (2007) · Hepatology · doi:10.1002/hep.21612 · Cited by 348
Self-citationThe clinical significance of persistently normal ALT in chronic hepatitis B infection
Lai, M., Hyatt, B. J., Nasser, I. A., Curry, M. P., & Afdhal, N. H. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.022 · Cited by 335
Chen, Y., Sheen, I. –., Chu, C., & Liaw, Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.36026 · Cited by 325
Self-citationRapti, I., Dimou, E., Mitsoula, P., & Hadziyannis, S. J. (2007) · Hepatology · doi:10.1002/hep.21534 · Cited by 323
Lampertico, P., Viganò, M., Manenti, E., Iavarone, M., Sablon, E., & Colombo, M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.079 · Cited by 310
Hsu, C., Hsiung, C. A., Su, I.-J., Hwang, W.-S., Wang, M.-C., Lin, S.-F., Lin, T.-H., Hsiao, H.-H., Young, J.-H., Chang, M.-C., et al. (2008) · Hepatology · doi:10.1002/hep.22106 · Cited by 305
Chu, C., Hung, S.-J., Lin, J., Tai, D., & Liaw, Y. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.040 · Cited by 287
Self-citationGane, E. J., Angus, P. W., Strasser, S., Crawford, D. H. G., Ring, J., Jeffrey, G. P., & McCaughan, G. W. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.005 · Cited by 273
Self-citationLampertico, P., Viganò, M., Manenti, E., Iavarone, M., Lunghi, G., & Colombo, M. (2005) · Hepatology · doi:10.1002/hep.20939 · Cited by 272
Hui, C., Leung, N., Yuen, S., Zhang, H., Leung, K., Lu, L., Cheung, S. K. F., Wong, W., & Lau, G. K. (2007) · Hepatology · doi:10.1002/hep.21724 · Cited by 266
Self-citationFontana, R. J., Hann, H.-W. L., Perrillo, R. P., Vierling, J. M., Wright, T., Rakela, J., Anschuetz, G., Davis, R., Gardner, S. D., & Brown, N. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.35352 · Cited by 264
Flink, H. J., van Zonneveld, M., Hansen, B. E., de Man, R. A., Schalm, S. W., Janssen, H. L. A., & for the HBV 99-01 Study Group* (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00418.x · Cited by 262
Livingston, S. E., Simonetti, J. P., Bulkow, L. R., Homan, C. E., Snowball, M. M., Cagle, H. H., Negus, S. E., & McMahon, B. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.010 · Cited by 256
Papatheodoridis, G. V., Manesis, E., & Hadziyannis, S. J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00094-5 · Cited by 246
Yuen, M.-F., Wong, D. K.-H., Sablon, E., Tse, E., Ng, I. O.-L., Yuan, H.-J., Siu, C.-W., Sander, T. J., Bourne, E. J., Hall, J. G., et al. (2004) · Hepatology · doi:10.1002/hep.20240 · Cited by 243
Fried, M. W., Piratvisuth, T., Lau, G. K. K., Marcellin, P., Chow, W.-C., Cooksley, G., Luo, K.-X., Paik, S. W., Liaw, Y.-F., Button, P., et al. (2008) · Hepatology · doi:10.1002/hep.22065 · Cited by 235
Self-citation&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200104000-00030 · Cited by 232
Chen, C., Hung, C., Lee, C., Hu, T., Wang, J., Wang, J., Lu, S., & Changchien, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.002 · Cited by 231
Determinants for Sustained Hbeag Response to Lamivudine Therapy
Chien, R.-N., Yeh, C.-T., Tsai, S.-L., Chu, C.-M., & Liaw, Y.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50458 · Cited by 214
Self-citationNi, Y.-H., Chang, M.-H., Wang, K.-J., Hsu, H.-Y., Chen, H.-L., Kao, J.-H., Yeh, S.-H., Jeng, Y.-M., Tsai, K.-S., & Chen, D.-S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.048 · Cited by 213
Self-citationChan, H. L. Y., Heathcote, E. J., Marcellin, P., Lai, C.-L., Cho, M., Moon, Y. M., Chao, Y.-C., Myers, R. P., Minuk, G. Y., Jeffers, L., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-11-200712040-00183 · Cited by 192
Vandepapelière, P., Lau, G. K. K., Leroux-Roels, G., Horsmans, Y., Gane, E., Tawandee, T., Merican, M. I. B., Win, K. M., Trepo, C., Cooksley, G., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.072 · Cited by 180
Self-citationChu, C., & Liaw, Y. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.039 · Cited by 174
Self-citationKao, J., Chen, P., Lai, M., & Chen, D. (2004) · Journal of Medical Virology · doi:10.1002/jmv.10534 · Cited by 170
Self-citationChu, C.-M., & Liaw, Y.-F. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.018 · Cited by 163
Self-citationChu, C., & Liaw, Y. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00810.x · Cited by 156
Self-citationFung, S. K., Wong, F. S.-H., Hussain, M., & Lok, A. S.-F. (2004) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2004.00556.x · Cited by 139
Hepatitis B reactivation after chemotherapy: two decades of clinical research
Lau, G. K. K. (2008) · Hepatology International · doi:10.1007/s12072-008-9056-3 · Cited by 128
Self-citationHealth‐related quality of life in chronic hepatitis B patients†
Ong, S. C., Mak, B., Aung, M. O., Li, S., & Lim, S. G. (2008) · Hepatology · doi:10.1002/hep.22138 · Cited by 127
Hepatitis B Virus Replication and Liver Disease Progression: The Impact of Antiviral Therapy
Liaw, Y. (2006) · Antiviral Therapy · doi:10.1177/135965350601100614 · Cited by 126
Self-citationJang, J. W., Choi, J. Y., Bae, S. H., Kim, C. W., Yoon, S. K., Cho, S. H., Yang, J. M., Ahn, B. M., Lee, C. D., Lee, Y. S., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.05.014 · Cited by 122
Flink, H. J., Sprengers, D., Hansen, B. E., van Zonneveld, M., de Man, R. A., Schalm, S. W., & Janssen, H. L. A. (2005) · Gut · doi:10.1136/gut.2004.062208 · Cited by 119
Buster, E. H. C. J., Hansen, B. E., Buti, M., Delwaide, J., Niederau, C., Michielsen, P. P., Flisiak, R., Zondervan, P. E., Schalm, S. W., & Janssen, H. L. A. (2007) · Hepatology · doi:10.1002/hep.21723 · Cited by 115
Chien, R., Lin, C.-H., & Liaw, Y. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00419-1 · Cited by 111
Self-citationOmata, M., & Sarin, S. K. (2008) · Hepatology International · doi:10.1007/s12072-008-9089-7 · Cited by 110
Chou, Y.-C., Yu, M., Wu, C.-F., Yang, S.-Y., Lin, C.-L., Liu, C.-J., Shih, W.-L., Chen, P.-J., Liaw, Y., & Chen, C.-J. (2007) · Gut · doi:10.1136/gut.2006.114066 · Cited by 108
Self-citationLong-Term Outcome in Children with Chronic Hepatitis B: A 24-Year Observation Period
Iorio, R. F., Giannattasio, A., Cirillo, F., D'Alessandro, L., & Vegnente, A. (2007) · Clinical Infectious Diseases · doi:10.1086/521864 · Cited by 103
Yokosuka, O., Omata, M., Imazeki, F., Okuda, K., & Summers, J. W. (1985) · Hepatology · doi:10.1002/hep.1840050505 · Cited by 101
Role of viral factors in the natural course and therapy of chronic hepatitis B
Kao, J. (2007) · Hepatology International · doi:10.1007/s12072-007-9033-2 · Cited by 94
Self-citationLong‐term outcome of chronic hepatitis B based on histological grade and stage
Park, B. K., Park, Y. N., Ahn, S. H., Lee, K. S., Chon, C. Y., Moon, Y. M., Park, C., & Han, K. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04857.x · Cited by 90
Self-citationChan, H. L., Wang, H., Niu, J., Chim, A. M., & Sung, J. J. �. (2007) · Antiviral Therapy · doi:10.1177/135965350701200308 · Cited by 85
Piratvisuth, T., Lau, G. K. K., Chao, Y., Jin, R., Chutaputti, A., Zhang, Q.-B., Tanwandee, T., Button, P., & Popescu, M. (2008) · Hepatology International · doi:10.1007/s12072-007-9022-5 · Cited by 79
Self-citationHepatitis B virus DNA prediction rules for hepatitis B e antigen–negative chronic hepatitis B
Feld, J. J., Ayers, M., El-Ashry, D., Mazzulli, T., Tellier, R., & Heathcote, J. (2007) · Hepatology · doi:10.1002/hep.21811 · Cited by 76
Spontaneous relapse of hepatitis in inactive HBsAg carriers
Chu, C., & Liaw, Y. (2007) · Hepatology International · doi:10.1007/s12072-007-9002-9 · Cited by 72
Self-citationSarin, S. K., Sood, A., Kumar, M., Arora, A., Amrapurkar, D., Sharma, B. C., Konar, A., Chawla, Y. K., Jain, R. K., Nanda, V., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01006.x · Cited by 63
Mahmood, S., Niiyama, G., Kamei, A., Izumi, A., Nakata, K., Ikeda, H., Suehiro, M., Kawanaka, M., Togawa, K., & Yamada, G. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01077.x · Cited by 54
Jonas, M. M., Little, N. R., Gardner, S. D., & Members of the International Pediatric Lamivudine Investigator Group (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00891.x · Cited by 48
HANN, H.-W. L., Chae, H. B., & Dunn, S. (2008) · Hepatology International · doi:10.1007/s12072-008-9045-6 · Cited by 43
Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues
Leung, N. W. Y. (2008) · Hepatology International · doi:10.1007/s12072-008-9061-6 · Cited by 39
Self-citationGane, E. J. (2008) · Hepatology International · doi:10.1007/s12072-008-9083-0 · Cited by 33
Self-citationThe economics of treating chronic hepatitis B in Asia
Dan, Y. Y., Aung, M. O., & Lim, S. G. (2008) · Hepatology International · doi:10.1007/s12072-008-9049-2 · Cited by 33
Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B
Piratvisuth, T. (2008) · Hepatology International · doi:10.1007/s12072-008-9046-5 · Cited by 21
Self-citationChien, R. (2008) · Hepatology International · doi:10.1007/s12072-008-9066-1 · Cited by 11
Cited by
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Liaw, Y.-F., & Chu, C.-M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60207-5 · Cited by 1,218
Self-citationAsian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Liaw, Y.-F., Kao, J.-H., Piratvisuth, T., Chan, H. L. Y., Chien, R.-N., Liu, C.-J., Gane, E., Locarnini, S., Lim, S.-G., Han, K.-H., et al. (2012) · Hepatology International · doi:10.1007/s12072-012-9365-4 · Cited by 1,038
Self-citationChang, T.-T., Liaw, Y.-F., Wu, S.-S., Schiff, E., Han, K.-H., Lai, C.-L., Safadi, R., Lee, S. S., Halota, W., Goodman, Z., et al. (2010) · Hepatology · doi:10.1002/hep.23785 · Cited by 972
Self-citationYang, H.-I., Yuen, M.-F., Chan, H. L.-Y., Han, K.-H., Chen, P.-J., Kim, D.-Y., Ahn, S.-H., Chen, C.-J., Wong, V. W.-S., & Seto, W.-K. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70077-8 · Cited by 669
Self-citation
Metadata
- Authors
- Liaw, Y.-F., Leung, N., Kao, J.-H., Piratvisuth, T., Gane, E., Han, K.-H., Guan, R., Lau, G. K. K., Locarnini, S., & for the Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver
- Venue
- Hepatology International
- Published
- 2008-05-10
- Volume
- 2
- Issue
- 3
- Pages
- 263-283
- ISSN
- 1936-0533 (ISSN-L)
- 1936-0541
- OpenAlex
- W2943463865
- Cited by
- 867
- References
- 81
- FWCI
- 60.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.